Koers Pharma-Bio Serv, Inc. Other OTC
Aandelen
PBSV
US71711N1000
Bedrijfsondersteunende diensten
Omzet 2024 * | 12,8 mln. 11,97 mln. | Omzet 2025 * | 20,2 mln. 18,89 mln. | Marktkapitalisatie | 16,88 mln. 15,78 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 1,32 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,84 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 34,4% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Victor Sanchez
CEO | Chief Executive Officer | 53 | 01-01-11 |
Pedro Lasanta
DFI | Director of Finance/CFO | 64 | 05-11-07 |
Sandra Molina
COO | Chief Operating Officer | - | 01-01-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dov Perlysky
BRD | Director/Board Member | 61 | 01-01-04 |
Kirk Michel
CHM | Chairman | 68 | 25-01-06 |
Howard Spindel
BRD | Director/Board Member | 78 | 25-01-06 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,13% | 7,41 mld. | |
-32,64% | 3,24 mld. | |
+5,82% | 2,66 mld. | |
+11,38% | 1,75 mld. | |
-9,32% | 1,08 mld. | |
+31,69% | 907 mln. | |
-7,64% | 714 mln. | |
-3,60% | 606 mln. | |
-8,30% | 539 mln. |